FMT for Post-acute COVID-19 Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
Symptom Clusters and Risk Factors of COVID-19 Patients
- Status
- COMPLETED
- Phase
- N/A
COVID-19 iCura SARS-CoV-2 Ag OTC: Clinical Evaluation
- Status
- COMPLETED
- Phase
- NA
The Efficacy and Safety of TADIOS as an Adjuvant Therapy in Patients Diagnosed With Mild to Moderate COVID-19
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above
- Status
- UNKNOWN
- Phase
- PHASE1
COVID RESPONSE STUDY (COVRES)
- Status
- COMPLETED
- Phase
- N/A
Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a
- Status
- COMPLETED
- Phase
- PHASE1
Co-design of a Digital Health Solution to Monitor Persisting Symptoms Related to COVID-19 Using Voice
- Status
- COMPLETED
- Phase
- N/A
Safety and Immunogenicity of Inactivated Heterologous Booster Vaccination
- Status
- WITHDRAWN
- Phase
- PHASE3
COVID Booster in Pregnancy and Lactation
- Status
- COMPLETED
- Phase
- N/A
PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
- Status
- COMPLETED
- Phase
- PHASE3
Long COVID-19 Syndrome in Primary Care: A Novel Protocol of Exercise Intervention "CON-VIDA Clinical Trial"
- Status
- UNKNOWN
- Phase
- NA
COVID-19 Fourth Dose Study in Australia
- Status
- WITHDRAWN
- Phase
- PHASE3
Booster Study of SpikoGen COVID-19 Vaccine
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Immunogenicity of the RNA MCTI CIMATEC HDT Vaccine
- Status
- UNKNOWN
- Phase
- PHASE2
Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia
- Status
- WITHDRAWN
- Phase
- PHASE1
Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People
- Status
- COMPLETED
- Phase
- PHASE1
Evaluating the Safety and Efficacy of AD17002 Intranasal Spray in Treating Participants With Mild to Moderate COVID-19
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Engaging Church Health Ministries to Decrease Coronavirus Disease-19 Vaccine Hesitancy in Underserved Populations
- Status
- WITHDRAWN
- Phase
- NA